(OR 1.14, CI 1.07-1.20). Patients with subsidized insurance had an almost twofold increased risk (OR 1.88, CI 1.42-2.50). Smoking, obesity, hypertension, diabetes mellitus, renal insufficiency, tachycardia, hypotension, leukocytosis, and neutrophilia were not more frequent in readmitted patients. Conclusions: Older age and subsidized insurance were associated with readmission whereas severity indicators for infection including abnormal vital signs and laboratory markers were not significantly associated. Factors other than severity of infection, such as socioeconomic factors, may influence clinical decisions related to readmission for LLC.
gram, skin and soft tissue infections remain a frequent reason for hospitalization with substantial allocation of resources directed towards evaluation and management in the acute care setting [1] [2] [3] [4] [5] [6] . In 2011, total hospital charges to Medicare for the cellulitis diagnosis-related group exceeded USD 5.1 billion, of which USD 1.08 billion was reimbursed [6] . In addition to increasing cost of care, unnecessary rehospitalization for cellulitis may result in further clinical investigations with low diagnostic yield (i.e. imaging studies), extended antibiotic courses, line placements, hospital-acquired infections, and delayed return to usual activities.
Acute care providers and consultants have an opportunity to contribute to hospital cost efficiency initiatives, and to the broader national agenda on improving value of care, by participating in coordination of care efforts after initial discharge and by supporting clinical decisionmaking around readmission for lower limb cellulitis (LLC) -the anatomic site accounting for the majority of cellulitis cases [1] [2] [3] . However, readmission for cellulitis, and more specifically LLC, is poorly understood. There is little evidence with which to identify LLC patients at risk for readmission. The purpose of this study is to characterize the LLC readmission cohort, and to investigate whether demographics, comorbidities, vital signs and laboratory markers of infection on initial admission for LLC are associated with readmission.
Materials and Methods
For further details, see the supplementary materials (for all online suppl. material, see www.karger.com/doi/10.1159/000471762) ( Fig. 1 ) .
Results
There were 4,224 admissions for LLC among 3,746 unique patients during the 5-year study period. Patient characteristics of the unique patients with LLC are listed in Table 1 Results from univariate and multivariate analyses are listed in Table 3 . In univariate modeling, LLC patients readmitted within 30 days were more likely to be older, have abnormal kidney function, and subsidized insurance compared to those not readmitted. There was a 9% increase in odds of readmission for every 10 years of age (OR 1.09, CI 1.03-1.15). Patients with abnormal creatinine had a 1.25-fold increased odds of readmission (CI 1.01-1.54), and those with subsidized insurance had a 1.51-fold increased odds of readmission (CI 1.05-1.97). In the multivariate model, there was a 14% increase in odds of readmission for every 10 years of age (OR 1.14, CI 1.07-1.20). The likelihood of readmission was also increased among patients with subsidized insurance (OR 1.88, CI 1.42-2.50).
Discussion and Conclusions
In this study, we have characterized the cohort of patients readmitted with LLC. The overall 30-day readmission rate for LLC was 11.2%. We observed a 14% increase in readmission odds for every 10-year increase in age. LLC patients with subsidized insurance had an 88% increase in the risk of readmission. Comorbidities including tobacco smoking, obesity, diabetes mellitus or hypertension were not associated with readmission, nor were vital signs or laboratory markers suggestive of infection. This contrasts with length of hospital stay, for which obesity, diabetes mellitus, tachycardia, hypotension, leukocytosis, neutrophilia, and renal insufficiency are associated with increased days to discharge [7] . Readmission rates for LLC have not previously been described. In comparison, historical Medicare data showed an all-cause 30-day readmission rate of 18.5% in 2012 [8] .
In our LLC cohort, the strongest finding was that readmission was nearly twice as likely in patients with subsidized insurance. The retrospective nature of this study precluded analysis of socioeconomic factors which may have influenced readmission. However, our observation on the Medicaid subgroup appears to approximate those for Medicaid patients in general [9] , and for Medicaid patients with other medical conditions such as heart failure [10] . The potential socioeconomic related influences on health, such as diminished access to care, warrant further study.
Based on our findings, we postulate the existence of factors other than comorbidities and clinical indicators of infection severity that may impact the readmission decision. In many instances leading to readmission, patients who present to subacute outpatient care are assessed as having failed hospital-based antibiotic strategies because of persistence of the red leg at the time of follow-up. However, some of these patients may be misdiagnosed and may instead have stasis dermatitis, lipodermatosclerosis, or contact dermatitis as an example, and thus would not have responded to treatment with intravenous antibiotics. The distinction of cellulitis among its mimics is based primarily on morphological features, and several studies have highlighted challenges in diagnostic accuracy among physicians given the broad differential diagnosis for the red leg [11] [12] [13] . Coordinating follow-up care for candidates at higher risk of readmission with consultants who may aptly distinguish common mimics of LLC also has the potential to diminish direct and indirect costs associated with rehospitalization, while improving quality and satisfaction of care.
However, uncertainty of diagnosis and misdiagnosis are unlikely to be the only contributors to potential overutilization of the hospital admission for LLC. Comorbid illness, compliance issues, social factors, and patient preference, in addition to the assessment of illness severity, likely contribute to the complexity in decision-making around the readmission. Perhaps most importantly, the absence of validated severity and admission criteria for LLC may account for the variance in real-world practice and utilization related to hospitalization of patients who may be treated safely at home or in the ambulatory setting. While expert panel recommendations and treatment guidelines have been proposed [14] [15] [16] , the primary data supporting clinical decisions related to acute care for cellulitis are limited and not yet validated. As such, there is a need to construct algorithms to establish severity of illness and the necessity for hospital admission with the goal of improving quality, satisfaction, and cost efficiency. We propose that admission criteria include case definition for cellulitis and exclude other soft tissue infections, such as abscesses. Criteria should also address anatomic locations since cellulitis of the face or finger, as examples, may have risk profiles, course and management strategies distinct from LLC. Since diagnostic accuracy may depend on individual provider experience, and because consultative services that assist in distinguishing other causes of the red leg(s) may not be immediately available, LLC admission criteria should also be designed to perform well when applied to noninfectious "pseudocellulitis" conditions presenting as candidate admission. The strengths of our study include the cohort diversity and size derived from tertiary and community hospitals in a regional health system, exclusion of other types of soft tissue infections, as well as exclusion of other sites of anatomic involvement. There are several limitations to this study, which bear consideration. Unavailable data in some instances related to practice variation in laboratory order sets limited multivariate analyses. For example, almost all providers ordered complete blood cell counts on admitted patients, but very few ordered a blood count differential. As such, we could not include band count, and for the same reason, other laboratory values such as acute phase reactants, in our analyses. We cannot account for all potential confounders in this observational analysis. However, use of the backward stepwise selection algorithm mitigated the statistical impact of confounders. We did not explore all biological factors, such as antibiotic resistant strains, that may influence readmission. We could not account for readmissions outside of the hospitals from which our data are captured, although the frequency of health system crossover in the community is generally low. Nevertheless, the number of readmissions may be underestimated. While our data are derived from both community and tertiary centers within the health system, it is unclear whether our observations are generalizable. Odds ratios for variables remaining in the final model after a backward selection algorithm. 2 Multivariable modeling included age as a continuous variable; odds ratio represents the odds of readmission within 30 days for every 10-year increase in age, after controlling for all other variables in the model. In summary, increasing age and subsidized insurance identify LLC patients at risk for readmission, whereas comorbidities and clinical markers indicating severity of infection do not. Factors other than severity of infection influence the clinician's decision on readmission, and these should be explored further to support quality and cost efficiency initiatives around LLC. Characterization of LLC patients at risk for readmission may help guide hospitalists and ambulatory-based physicians in coordinating care for such individuals after initial discharge with the goal of improving quality of care while reducing cost.
Key Message
Factors other than markers of disease severity influence readmission of patients with lower limb cellulitis.
